Zurcher Kantonalbank (Zurich Cantonalbank) Nkarta, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $34.1 Billion
  • Q4 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 01, 2023
BUY
$5.14 - $14.35 $8,547 - $23,864
1,663 New
1,663 $9,000
Q1 2022

Apr 21, 2022
SELL
$8.66 - $14.99 $7,759 - $13,431
-896 Closed
0 $0
Q4 2021

Feb 01, 2022
SELL
$12.79 - $26.88 $1,202 - $2,526
-94 Reduced 9.49%
896 $14,000
Q3 2021

Nov 15, 2021
SELL
$26.67 - $38.76 $240 - $348
-9 Reduced 0.9%
990 $28,000
Q2 2021

Jul 30, 2021
BUY
$23.94 - $36.68 $1,149 - $1,760
48 Added 5.05%
999 $32,000
Q1 2021

May 03, 2021
BUY
$31.33 - $59.61 $29,794 - $56,689
951 New
951 $31,000

Others Institutions Holding NKTX

# of Institutions
126
Shares Held
66.5M
Call Options Held
173K
Put Options Held
20K
View Full List

About Nkarta, Inc.

NKTX Quotes by TradingView
  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $116M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email